In order to increase the tissue level of tetrahydrobiopterin (BH 4 ), supplementation with 6R-tetrahydrobiopterin (6RBH4) has been widely employed. In this work, the profile of BH 4 accumulation was compared between the liver and the small intestine after feeding with 10mg/kg of 6RBH 4 or 7,8-dihydrobiopterin (7,8BH 2 ). Endogenous BH 4 was 7.20 ± 0.28 and 1.59 ± 0.13 nmol/g in the liver and the intestine, respectively. BH 4 levels rose to 12.5 ± 1.35 (1.7-fold) and 53.0 + 19.6 nmol/g (40-fold) in the liver and the intestine within 30 min, respectively. Administration of 7,8BH 2 caused an even higher rise in BH 4 (14.4 ± 2.79 nmol/g) in the liver, while it led to a considerable increase in tissue BH 2 in the intestine. When dihydrofolate reductase inhibitor MTX was administered before the pterin feeding, BH 4 did not increase in the liver, while it increased 20-fold in the intestine, although the rise was 45% less than that in the absence of MTX. These results suggest that 1) the liver was scarcely able to uptake BH 4 in its reduced form; 2) accumulation of BH 4 in the liver was achieved through the MTX-sensitive pathway presumably driven by dihydrofolate reductase; 3) a large concentration of BH 4 accumulated in the intestine, bypassing the MTX-sensitive pathway, that is, it was taken up directly as the fully reduced form, BH 4 ; 4) the other BH 4 accumulated in the intestine seemed to have been converted from BH 2 through the MTX-sensitive pathway, as in the liver.
Introduction
6-(R)-L-erv7/7/O-5,6,7,8-Tetrahydrobiopterin (6RBH 4 ) is an essential cofactor of aromatic amino acid hydroxylases, phenylalanine-(1), tyrosine- (2) and tryptophan-hydroxylase (3, 4) . The biosynthesis of classic monoamines such as dopamine, noradrenaline, adrenaline as well as serotonin is dependent on the cofactor BH 4 . Furthermore, BH 4 is also the cofactor of NO-synlhase (NOS) (5, 6 ). An insufficient supply of BH 4 results in a lowered production of monoamines and an uncontrolled release of active oxygen concomitant with inadequate NO production, which might lead to various disorders regarding neural function and blood circulation, respectively (7, 8) . Regarding BH 4 therapy for patients with BH 4 insufficiency, however, the efficiency of BH 4 uptake has not been appreciated (9) (10) (11) . We have been working on permeability and the metabolic fate of exogenously administered BH 4 with cultured cells and in vivo in mouse. In our in vitro w ork using cultured RBL2H3 and PC 12 cells, uptake of BH 4 was shown to be hampered by some cellular processes resulting in poor incorporation, while sepiapterin and 7.8BH 2 were incorporated and converted into BH 4 in an efficient manner (12) (13) (14) (15) (16) . We observed in mice that orally administered BH 4 resulted in an appreciable elevation of tissue BII 4 levels in organs such as the liver and kidney (17) . Remarkably, the increased portion of BH 4 was revealed to have been converted from BH 2 by a MTX-sensitive manner in most organs examined, presumably by the enzymatic action of dihydrofolate reductase (18) . In the same work, we noticed a very steep rise in BH 2 levels in the blood circulation following oral administration of 6RBH 4 . In this study, we examined biopterin accumulation (BH 4 and BH 2 ) in intestinal mucosa and the liver after feeding 6RBH 4 CM-cellulose (medium viscosity, sodium salt) was obtained from Fluka (Buchs, Switzerland). C57BL/6J mice were from Japan SLC (Hamamatsu, Japan) and adult males 10 weeks of age were used in the present experiments. The animals were maintained on an ordinary laboratory chow and tap water ad libidunu under a constant 1 2-h light-dark cycle. The experiments were conducted in accordance with the ethical guidelines of the Teikyo University of Science and Technology Animal Experimentation Committee.
Pterins were given to animals at a dose of 10mg/kg body weight. The pterin compounds were dissolved in 0.05 Ν HCl just prior to oral administration (p.o.). When MTX was given, the reagent was suspended in aqueous 2% CM-cellulose and was administered 90 min before the pterins. The liver and small intestine were dissected under anaesthesia. The proximal third of the small intestine was taken and opened longitudinally, washed with cold saline, blotted three times with filter paper to remove the mucus coat, weighed, frozen immediately in liquid N 2 . and then stored at -80°C until determination.
Frozen tissues were partially thawed and homogenized immediately in a 5 vol of 0.1 Ν HCl. An aliquot ( 100 μι.) of the homogenate was mixed with a 0.5 vol of an acid-iodine solution (2% I 2 . 3% KI in 0.1 Ν HCl), or with alkaline-iodine (2% l 2 , 3% KI in 0.2 Ν NaOH) for oxidation under acid or alkaline conditions, respectively ( 19) . The oxidation reaction was allowed to proceed for 1 h at room temperature. After addition of a 0.5 vol of ascorbic acid (2.5%) dissolved in perchloric acid (0.4 M), a clear solution was obtained by centrifugation at 1 (),()()() χ g for 10 min. Biopterin and pterin were determined by HPLC equipped with a fluorescence detector (Ex=350 and Em=450 nm). The solid phase was Fine-SIL C18T-5 and the mobile phase was 7% methanol. Biopterin measured after acid-l 2 oxidation was taken as the "total biopterin". The diffcrcncc between the biopterin quantity after acid-oxidation and that after alkaline-oxidation was termed "BH 4 " throughout this paper. Since the amount of fully oxidized biopterin detected in fresh tissue extracts was insignificant, the biopterin calculated from the "total biopterin" minus "BH 4 " was termed "BH : ".
When 6-(R)-L-erv?/7ro-tetrahydrobioptcrin was specified as a reagent, "6RBH 4 " was used instead of "BH 4 ". For example, a working solution of the reagent BH, for administration to mice was termed "6RBH 4 ".
Results and Discussion
In order to measure intestinal absorption of orally administered BH 4 , we gave 6RB11 4 at a dose of 10 mg/kg to mice (C57BL/6J 10 week, male), then biopterin uptake (BH 4 and BH 2 ) was measured in the liver and intestine after administration.
Increase in biopterin (BH 4 and BH 2 ) in the liver was first examined after administration. The liver contained endogenous biopterin at a level of 7.64 ± 0.32, of which 94.2% was the fully reduced form, BH 4 . When 6RBH 4 was given orally, biopterin content increased to about 2-fold within 30 min. continued to increase, and reached more than 5-fold at 120 min, then decreased gradually. As mentioned previously (18), a steep BH 2 surge appeared in the blood 30-60 min after 6RBH 4 administration. Since liver cells contain dihydrofolate reductase DHFR which converts 7.8BH 2 to BH 4 . some portion of the BH 4 might be derived from 7,8BH 2 . In order to analyze the contribution of the DHFR-pathway, an inhibitor, MTX, was administered 90 min prior to 6RBH 4 administration, then incorporation of biopterin in the liver was measured, as shown in Fig. I b. MTX administration did not alter the endogenous content of total biopterin but significantly lowered the percentage of BH 4 (designated as "%BH 4 ") to 76.6%, suggesting that the MTX-sensitive pathway was involved to a considerable extent in maintaining the endogenous level. When 6RBH 4 was given to the animals in the absence of MTX, liver BH 4 rose up to 1.7-fold with a constant %BH 4 (95.4%). In the presence of MTX, total biopterin also increased up to 1.58-fold, however. BH 4 scarcely rose and consequent %BH 4 decreased to 57.7%, therefore, a large quantity of 7,8BH 2 appeared. The large quantity of BH2 might otherwise be converted to BH 4 by an MTX-sensitive pathway. 7,8BH 2 administration at the same dose raised the liver BH 4 completely inhibited by MTX, while the uptake of BH 2 was not strongly inhibited. These results suggested that the large part of the BH 4 increase after the administration of either BH 4 or BH 2 was driven by the MTX-sensitive pathway. It should be emphasized that the liver took up BH 2 and converted it to BH 4 , even when 6RBH 4 has been given to the rat, indicating that BH 4 had been previously oxidized somewhere.
Tissue biopterin of the small intestine was 1.75+0.12 nmol/g and 91.2% was BH 4 : the endogenous level was roughly one fourth of the liver. As shown in Fig. la , administration of 6RBH 4 raised the tissue biopterin level up to 71.3 ± 26.6 nmol/g within 30 min, more than 40-fold over the endogenous level. The amount of BH 2 was considerable (25.5% of total biopterin). The increase in BH 2 after BH 4 administration was not accompanied with any rise in pterin, which is an autooxidation product of BH 4 at neutral pH. Therefore, the observed large quantity of BH 2 was unlikely to have been produced through the autooxidation of administered 6RBH 4 . The high level of accumulated BH 4 did not last a long time but decreased gradually. In the presence of MTX, a large increase in BH 4 was also observed (ca. 20-fold over endogenous BH 4 ), although the increase was 45% less than in the absence of MTX. This difference was possibly due to inhibition of the conversion of BH 2 to BH 4 by MTX. The observed increase in BH 4 was, therefore, accumulated bypassing the MTX-sensitive pathway, suggesting that this BH 4 was taken up directly without prePteridines/Vol. 16/No. 1 ceding oxidation to 7,8BH 2 and subsequent reduction to BH 4 unlike in the liver. When 7,8BFL was given, the bioperin level increased comparably, but mostly as BH 2 , which greatly contrasted to the liver, in which most of the biopterin increase was in the form of BH 4 .
Conclusion
When 6RBH4 was orally administered, we examined how the pterin was absorbed in the intestine and delivered throughout the body, including the liver. In this study, biopterin accumulation after 6RBH 4 administration in the liver was first analyzed in the presence and absence of a representative antifolate, MTX. Then the profile of biopterin accumulation in the intestine was compared with that of the liver. The observed increase in BH 4 amount was completely inhibited by MTX in the liver, suggesting that most of the increase in BH 4 was achieved through an MTX-sensitive pathway. The liver was, therefore, judged to take up BH 2 selectively but not BH 4 . Presumably as a consequence, the efficiency of BH 4 increase in the liver after Bll 2 administration was not less than that with 6RBH 4 . On the contrary, intestinal increase in BH 4 after pterin feeding was only partially inhibited by MTX, suggesting that the MTX-insensitive portion of the observed rise in BH 4 level was caused by direct uptake of 6RBH 4 as the fully reduced form. The other portion of the BH 4 increase involved the reduction of BH 2 by an MTX-sensitive pathway, like in the liver. It is unclear where the oxidation of BH 4 took place. The intestine was also shown to be able to uptake BH 2 , of which a large portion was not converted to BH 4 , unlike the liver. The intestine was therefore judged to uptake either BH 4 or BH 2 . The organ might release the absorbed biopterin, BH 4 and BH 2 , into the blood circulation. The liver takes up BH 2 selectively in the circulation and converts it to BH 4 by an MTX-sensitive manner as discussed above. The reason why the liver takes up BH 2 but not BH, directly is unknown. Practically, however, BH 2 rather than BH 4 uptake might be better to increase tissue BH 4 levels when BH 4 supplementation is required.
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